The Swiss biopharmaceutical company Light Chain Bioscience has developed a novel and unique class of human, bispecific antibodies dubbed κλ bodies, so-called because they combine a κ light ...

Bleiholder's team confirmed that structural variations among antibody populations are not influenced by glycosylation—a ... "Our study sheds new light on the relationship between the various ...